drugset / Trial / NCT05590793

Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

NCT05590793

Phase 3 Completed 195 enrolled Ipsen
NaSingle-groupOpen-labelTreatment

Summary

The main aim of this study is to assess the effectiveness and safety of the 6-month formulation of triptorelin pamoate in Chinese participants with locally advanced or metastatic cancer of the prostate. Participants will receive 1 injection of triptorelin pamoate 6-month formulation.

Timeline

Start
2022-11-17
Primary completion
2024-08-20
Completion
2024-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 22.5 mg Intramuscular